Bipolar Disorders and Cardiovascular Risk:  A Cardiologist's Perspective with a Psychiatry Twist

Francisco Lopez-Jimenez, M.D.

Introduction

Dr. Lopez-Jimenez is a Professor of Medicine at Mayo College of Medicine, the chair of the Division of Preventive Cardiology and the Director of Research at the Dan Abraham Healthy Living Center at Mayo.  He led the Consensus Statement in Cardiac Rehabilitation and Secondary Prevention for the Inter-American Society of Cardiology and the South American Society of Cardiology. He is also the Chair of the International Committee for the American Association of Cardiovascular and Pulmonary Rehabilitation.

Dr. Lopez-Jimenez did his cardiology fellowship at Mount Sinai Medical Center in Miami, Florida and at Brigham and Women’s Hospital, Harvard Medical School.  He trained in preventive cardiology at the VA Boston Healthcare System and Harvard Medical School and holds a Master’s of Science from Harvard School of Public Health. He has published more than 200 scientific publications, including invited editorials in journals like Lancet, and his scientific work has been cited more than 4000 times.  He is a member of the editorial boards of the American Journal of Cardiology, the Journal of Cardiopulmonary Rehabilitation and Prevention, the European Journal of Preventive Cardiology, Archives of Cardiology and the Journal of Clinical Investigation.  He has been frequently featured by the national media, including the New York Times, the Wall Street Journal, CNN and NBC, and has been a guest speaker at National Public Radio on his work on normal weight obesity and other studies challenging the clinical utility of BMI and supporting the use of alternative measures of body adiposity.

Learning Objectives

1. Describe the association between bipolar disorders and cardiovascular (CV) diseases.
2. Discuss the scientific evidence, or lack of, supporting interventions to reduce CV risk in bipolar disorder.
3. List the areas of further resarch needed to reduce the CV risk in bipolar disorders.

 
Live webcast available at:  http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live.  Ethos will be implemented for all post presentation surveys.  To document your attendance, please text the code given at the presentation to 507-200-3010.  For questions, email rstpsychgr@mayo.edu.

Credit Statements

• In support of improving patient care, Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
• Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
• The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content. 
• Archived webcast available at: Psychiatry & Psychology Video Library

Industry Acknowledgment (if applicable): None.

NEW in 2017 !!!

All participants MUST complete the evaluation in order to get CME or APA Credit. 

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.
 
Disclosure Summary
As a Jointly Accredited Provider by ACCME, ACPE, and ANCC, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:  NONE

No relevant financial relationship(s) with industry:
Mark Frye, M.D., Kriti Gandhi, M.D., Allison Holgerson, Ph.D., Matej Markota, M.D., Charlene Nelson, Reem Shafi, M.B.B.S., Larua Suarez, M.D.

Speaker:  Francisco Lopez-Jimenez, M.D.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:  NONE